Subclinical atherosclerosis, airflow obstruction and emphysema: The MESA Lung Study

European Respiratory Journal

Volumn 39, Issue 4, 2012, Pages 846-854

  Barr, R G ^a   Ahmed, F S ^a   Carr, J J ^b   Hoffman, E A ^c   Jiang, R ^a   Kawut, S M ^d   Watson, K ^e  

^a NewYork Presbyterian Hospital   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiopulmonary interactions; Cardiovascular epidemiology; Chronic; Emphysema; Obstructive pulmonary disease

Indexed keywords

C REACTIVE PROTEIN; CALCIUM;

ADULT; AGED; AIRWAY OBSTRUCTION; ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ARTICLE; CARDIAC IMAGING; CARDIOVASCULAR RISK; CAROTID ARTERY FLOW; CAROTID ATHEROSCLEROSIS; CIGARETTE SMOKING; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; SPIROMETRY;

AGED; AGED, 80 AND OVER; AIRWAY OBSTRUCTION; ANKLE BRACHIAL INDEX; CALCINOSIS; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CORONARY ARTERY DISEASE; EMPHYSEMA; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPIROMETRY; UNITED STATES;

EID: 84860343774     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00165410     Document Type: Article

References (52)

1. Miniño AM, Xu J, Kochanek KD. Deaths: preliminary data for 2008. Natl Vital Stat Rep 2010; 59: 1-52.
2. Kung HC, Hoyert DL, Xu JQ, et al. Deaths: final data for 2005. Natl Vital Stat Rep 2008; 56: 1-124.
3. Persson C, Bengtsson C, Lapidus L, et al. Peak expiratory flow and risk of cardiovascular disease and death: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Am J Epidemiol 1986; 124: 942-948. (Pubitemid 17207262)
4. Ebi-Kryston KL. Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study. J Clin Epidemiol 1988; 41: 251-260. (Pubitemid 18069585)
5. Cook DG, Shaper AG. Breathlessness, lung function and heart attack. Eur Heart J 1988; 9: 1215-1222. (Pubitemid 19010172)
6. Tockman M, Cornstock GW. Respiratory risk factors and mortality: longitudinal studies in Washington County, Maryland. Am Rev Respir Dis 1989; 140: S56-S63. (Pubitemid 19231336)
7. Sorlie PD, Kannel WB, O'Connor G. Mortality associated with respiratory function and symptoms in advanced age. The Framingham Study. Am Rev Respir Dis 1989; 140: 379-384. (Pubitemid 19218353)
8. Hole DJ, Watt GC, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley Prospective Population Study. BMJ 1996; 313: 711-715.
9. Schunemann HJ, Dorn J, Grant BJB, et al. Pulmonary function is a long-term predictor of mortality in the general population. Chest 2000; 118: 656-664.
10. Schroeder EB, Welch VL, Couper D, et al. Lung function and incident coronary heart disease: the Atherosclerosis Risk In Communities Study. Am J Epidemiol 2003; 158: 1171-1181. (Pubitemid 37548787)
11. Wannamethee SG, Shaper AG, Ebrahim S. Respiratory function and risk of stroke. Stroke 1995; 26: 2004-2010.
12. Strachan DP. Ventilatory function as a predictor of fatal stroke. BMJ 1991; 302: 84-87.
13. Truelsen T, Prescott E, Lange P, et al. Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study. Int J Epidemiol 2001; 30: 145-151. (Pubitemid 32203804)
14. Hozawa A, Billings JL, Shahar E, et al. Lung function and ischemic stroke incidence. Chest 2006; 130: 1642-1649.
15. Ebrahim S, Papacosta O, Whincup P, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke 1999; 30: 841-850. (Pubitemid 29156378)
16. Schroeder EB, Welch VL, Evans GW, et al. Impaired lung function and subclinical atherosclerosis: the ARIC Study. Atherosclerosis 2005; 180: 367-373. (Pubitemid 41072908)
17. Engstrom G, Hedblad B, Valind S, et al. Asymptomatic leg and carotid atherosclerosis in smokers is related to degree of ventilatory capacity: longitudinal and cross-sectional results from "Men born in 1914", Sweden. Atherosclerosis 2001; 155: 237-243. (Pubitemid 32167145)
18. Iwamoto H, Yokoyama A, Kitahara Y, et al. Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med 2009; 179: 35-40.
19. Zureik M, Kauffmann F, Touboul P-J, et al. Association between peak expiratory flow and the development of carotid atherosclerotic plaques. Arch Intern Med 2001; 161: 1669-1676. (Pubitemid 32681150)
20. Park HY, Lim SY, Hwang JH, et al. Lung function, coronary artery calcification, and metabolic syndrome in 4,905 Korean males. Respir Med 2010; 104: 1326-1335.
21. Celli BR, MacNee W, Agusti A, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946. (Pubitemid 38807371)
22. Barr RG, Bluemke DA, Ahmed FS, et al. Percent emphysema, airflow obstruction and impaired left ventricular filling. N Engl J Med 2010; 362: 217-227.
23. Bild DE, Bluemke DA, Burke GL, et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol 2002; 156: 871-881. (Pubitemid 35215769)
24. Hankinson J, Odencrantz J, Fedan K. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999; 159: 179-187. (Pubitemid 29036522)
25. O'Leary DH, Polak JF, Wolfson SK Jr, et al. Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. Stroke 1991; 22: 1155-1163.
26. McDermott MM, Criqui MH, Liu K, et al. Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures, and association with leg functioning in peripheral arterial disease. J Vasc Surg 2000; 32: 1164-1171.
27. Carr JJ, Nelson JC, Wong ND, et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development In Young Adults (CARDIA) study. Radiology 2005; 234: 35-43. (Pubitemid 39658367)
28. Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008; 358: 1336-1345. (Pubitemid 351468410)
29. Yaghoubi S, Tang W, Wang S. Offline assessment of atherosclerotic coronary calcium from electron beam tomograms. Am J Cardiac Imag 1995; 9: 231-236.
30. Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-832. (Pubitemid 20101575)
31. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338. (Pubitemid 41079078)
32. Hankinson JL, Kawut SM, Shahar E, et al. Performance of American Thoracic Society-recommended spirometry reference values in a multiethnic sample of adults: the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study. Chest 2010; 137: 138-145.
33. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968. (Pubitemid 41632054)
34. Guo J, Reinhardt JM, Kitaoka H, et al. Integrated system for CT-based assessment of parenchymal lung disease. IEEE International Symposium on Biomedical Imaging 2002. http://ieeexplore.ieee. org/xpl/freeabs-all.jsp? arnumber51029398 Date last accessed: February 7, 2012. Date last updated: July 10, 2002.
35. Coxson HO, Mayo JR, Behzad H, et al. Measurement of lung expansion with computed tomography and comparison with quantitative histology. J Applied Physiol 1995; 79: 1525-1530.
36. Hoffman EA, Jiang R, Baumhauer HA, et al. Reproducibility and validation of lung density measures from cardiac CT scans in the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study. Acad Radiology 2009; 16: 689-699.
37. Ferris BG. Epidemiology standardization project. Am Rev Respir Dis 1978; 118: 1-120.
38. McCullagh P, Nelder JA, eds. Generalized Linear Models. New York, Chapman & Hall, 1989.
39. Greenland S, Michels KB, Robins JM, et al. Presenting statistical uncertainty in trends and dose-response relations. Am J Epidemiol 1999; 149: 1077-1086. (Pubitemid 29270320)
40. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990; 1: 43-46. (Pubitemid 20255621)
41. Anderson AE Jr, Hernandez JA, Eckert P, et al. Emphysema in lung macrosections correlated with smoking habits. Science 1964; 144: 1025-1026.
42. Faxon DP, Fuster V, Libby P, et al. Atherosclerotic vascular disease conference: Writing Group III: Pathophysiology. Circulation 2004; 109: 2617-2625. (Pubitemid 38720566)
43. Komai H, Higami Y, Tanaka H, et al. Impaired flow-mediated endothelium-dependent and endothelium-independent vasodilation of the brachial artery in patients with atherosclerotic peripheral vascular disease. Angiology 2008; 59: 52-56. (Pubitemid 351253080)
44. Kasahara Y, Tuder RM, Cool CD, et al. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 2001; 163: 737-744. (Pubitemid 32230838)
45. Petrache I, Natarajan V, Zhen L, et al. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nature 2005; 11: 491-472.
46. Barr RG, Mesia-Vela S, Austin JH, et al. Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study. Am J Respir Crit Care Med 2007; 175: 1200-1207. (Pubitemid 350256473)
47. Hegele RA. The pathogenesis of atherosclerosis. Clin Chem Acta 1996; 246: 21-38. (Pubitemid 26096380)
48. Johnsen SH, Mathiesen EB. Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease. Curr Cardiol Rep 2009; 11: 21-27.
49. Tabara Y, Kohara K, Nakura J, et al. Risk factor-gene interaction in carotid atherosclerosis: effect of gene polymorphisms of renin-angiotensin system. J Hum Genet 2001; 46: 278-284. (Pubitemid 32410680)
50. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study. N Engl J Med 1999; 340: 14-22. (Pubitemid 29024679)
51. Jiang R, Burke GL, Enright PL, et al. Inflammatory markers and longitudinal lung function decline in the elderly. Am J Epidemiol 2008; 168: 602-610.
52. Folsom AR, Kronmal RA, Detrano RC, et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 2008; 168: 1333-1339. (Pubitemid 351930841)